SCHEMBL23486284

SCHEMBL23486284

CCOC(=O)c1nnsc1Cc1ccc(-c2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ILK Q13418 1/20 0.54
▸ TARBP2 Q15633 1/20 0.49
▸ CYP19A1 P11511 4/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ TSHR P16473 2/20 0.46
▸ MAPT P10636 3/20 0.45
▸ NPSR1 Q6W5P4 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ CDC7 O00311 1/20 0.44
▸ TRPM8 Q7Z2W7 1/20 0.44
▸ DBF4 Q9UBU7 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ RARA P10276 1/20 0.44
▸ RARB P10826 1/20 0.44
▸ RARG P13631 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23486286 0.92 ILK (0.59) ILKCYP19A1ALDH1A1TSHRMAPT
SCHEMBL22609346 0.88 ILK (0.52) ILKALDH1A1TSHRMAPTHSD17B10
SCHEMBL23453737 0.86 MAPT (0.43) ILKALDH1A1TSHRMAPTNPSR1
SCHEMBL23453738 0.85 ILK (0.47) ILKTARBP2CYP19A1ALDH1A1TSHR
SCHEMBL22609269 0.85 ILK (0.47) ILKALDH1A1TSHRMAPTNPSR1
SCHEMBL23486285 0.83 ALDH1A1 (0.50) ALDH1A1TSHRNPSR1MEN1KMT2A
SCHEMBL6815148 0.79 ILK (0.61) ILKTARBP2CYP19A1ALDH1A1TSHR
SCHEMBL23486367 0.73 KDM4E (0.51) —
SCHEMBL23486383 0.73 ALDH1A1 (0.47) ILKALDH1A1TSHRMAPTNPSR1
SCHEMBL23453753 0.71 SRD5A2 (0.54) ALDH1A1CYP1A2CYP2C9HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF ORFAN BIOTECH SL (ES) 2021-06-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF PNPO, XDH, GLS ILK 3208/4885TARBP2 4831/4885CYP19A1 1395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback